Showing results (411-420 of 501) with videos related to

Sort By:
Pageof 51
Journal of Hematology & Oncology|April 27, 2021
Targeting the metabolic vulnerability of acute myeloid leukemia blasts with a combination of venetoclax and 8-chloro-adenosineRalf Buettner, Le Xuan Truong Nguyen, Corey Morales, et al.
Cancers|November 27, 2021
Identification of a Distinct miRNA Regulatory Network in the Tumor Microenvironment of Transformed Mycosis FungoidesCosimo Di Raimondo, Zhen Han, Chingyu Su, et al.
Leukemia & Lymphoma|April 9, 2014
Phase II study of alemtuzumab-rituximab therapy in previously untreated patients with chronic lymphocytic leukemia: short- and long-term outcomesOlga Frankfurt, Shuo Ma, Leo Gordon, et al.
Oncotarget|October 8, 2016
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphomaAtish Mohanty, Natalie Sandoval, Manasi Das, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Novel antineoplastic agents with efficacy against multidrug resistant tumor cellsJ C Medina, B Shan, H Beckmann, et al.
JCI Insight|July 10, 2023
Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphomaZhen Han, Xiwei Wu, Hanjun Qin, et al.
Journal for Immunotherapy of Cancer|March 23, 2021
Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancerXu Cao, Bolei Li, Jing Chen, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 2, 2021
Evaluation of classic and novel ultrasound signs of placenta accreta spectrumD W Skupski, C M Duzyj, J Scholl, et al.
Cancer|October 28, 2023
A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokineticsVinod Pullarkat, Lisa S Chen, Joycelynne Palmer, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Phase I Trial of Brentuximab Vedotin Plus Cyclosporine in Relapsed/Refractory Hodgkin LymphomaSwetha Kambhampati Thiruvengadam, Matthew G Mei, Lu Chen, et al.
Pageof 51